@article{643c1cc0b7bd470dab1c303272cbb314,
title = "A novel ADAMTS17 variant that causes Weill-Marchesani syndrome 4 alters fibrillin-1 and collagen type I deposition in the extracellular matrix",
author = "Karoulias, {Stylianos Z.} and Aude Beyens and Zerina Balic and Sofie Symoens and Anthony Vandersteen and Rideout, {Andrea L.} and John Dickinson and Bert Callewaert and Dirk Hubmacher",
note = "Funding Information: This work was supported by a seed fund from the Leni and Peter W. May Department of Orthopedics, Icahn School of Medicine at Mount Sinai (United States) (D.H.). A.B. is supported by the Special Research Fund, Flanders of Ghent University (Belgium, grant 01N04516C to B.C.) and European Academy of Dermatovenereology (Switzerland, EADV project PPRC-2018-50 to B.C.). B.C. is a senior clinical investigator of the Research Foundation Flanders. The Ghent University Hospital is a member of the European Reference Network for skin disorders (ERN-skin). We thank Dr. Dieter Reinhardt (McGill University, Montreal, QC, Canada) for providing the fibrillin-1 antibody. Funding Information: This work was supported by a seed fund from the Leni and Peter W. May Department of Orthopedics , Icahn School of Medicine at Mount Sinai (United States) (D.H.). A.B. is supported by the Special Research Fund, Flanders of Ghent University (Belgium, grant 01N04516C to B.C.) and European Academy of Dermatovenereology (Switzerland, EADV project PPRC-2018-50 to B.C.). B.C. is a senior clinical investigator of the Research Foundation Flanders. The Ghent University Hospital is a member of the European Reference Network for skin disorders (ERN-skin). We thank Dr. Dieter Reinhardt (McGill University, Montreal, QC, Canada) for providing the fibrillin-1 antibody. Publisher Copyright: {\textcopyright} 2019 Elsevier B.V.",
year = "2020",
month = jun,
doi = "10.1016/j.matbio.2019.11.001",
language = "English",
volume = "88",
pages = "1--18",
journal = "Matrix Biology",
issn = "0945-053X",
publisher = "Elsevier",
}